Skip to main content
BIOMERICA INC logo

BIOMERICA INC — Investor Relations & Filings

Ticker · BMRA ISIN · US09061H3075 US Manufacturing
Open in API
Filings indexed 587 across all filing types
Latest filing 2021-12-10 Director's Dealing
Country US United States of America
Listing US BMRA

About BIOMERICA INC

https://biomerica.com/

Biomerica, Inc. is a global biomedical technology company that develops, patents, manufactures, and markets advanced in-vitro diagnostic (IVD) and therapeutic products. The company provides solutions for both laboratory and at-home testing, designed for the early detection and monitoring of chronic conditions. Its primary research and development focus is on gastrointestinal and inflammatory diseases, with a notable pipeline that includes a non-drug, diagnostic-guided therapy for Irritable Bowel Syndrome (IBS). Biomerica's products aim to enhance patient health and well-being while contributing to the reduction of total healthcare costs.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2021-12-10 English
PRIMARY DOCUMENT
Director's Dealing
2021-12-10 English
FORM 8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated December 9, 2021, for Biomerica, Inc. It reports the submission of matters to a vote of security holders at the 2021 Annual Meeting, including election of directors, advisory votes on executive compensation, frequency of advisory votes, and ratification of the independent auditor. The content is focused on the official results of shareholder votes at the annual meeting. The document length is 4561 characters, which is relatively short and contains detailed voting results, not just an announcement of a report. The key section is 'Item 5.07 Submission of Matters to a Vote of Security Holders,' which matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). Therefore, the document is best classified as DVA.
2021-12-10 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated December 2, 2021, by Biomerica, Inc. It reports the conclusion of an SEC investigation with no enforcement action recommended. The content is an announcement of an event (SEC investigation conclusion) rather than a full financial report or detailed management discussion. The document length is 3301 characters, which is relatively short and consistent with a regulatory announcement. There are no financial statements or detailed financial data present. Therefore, this filing is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-12-07 English
FORM 10-Q
Interim / Quarterly Report Q1 2022
2021-10-14 English
FORM 10-K/A
Annual Report FY 2021
2021-10-14 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.